Search
for
Sort by
Research 61–90 of 423
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Glucocorticoid Receptor Mutants Demonstrate Increased Motility Inside the Nucleus of Living Cells: Time of Fluorescence Recovery After Photobleaching (FRAP) Is an Integrated Measure of Receptor Function
- Hyperadrenocorticism in Ferrets
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Síndrome do ovário policístico: abordagem dermatológica
- Determining the normal cut-off levels for hyperandrogenemia in Chinese women of reproductive age
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Muscle pain in a woman with congenital adrenal hyperplasia due to 21-hydroxylase deficiency resolved with testosterone therapy. A case report with 10 years of follow-up
- Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry
- Penis Endocrinology
- Prostate-specific antigen as a diagnostic marker in female hyperandrogenism
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Steroid Biomarkers and Genetic Studies Reveal Inactivating Mutations in Hexose-6-Phosphate Dehydrogenase in Patients with Cortisone Reductase Deficiency
- Toward a Diagnostic Score in Cushing's Syndrome
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- 5α-Reduced glucocorticoids: a story of natural selection
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Progestogens in menopausal hormone therapy
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
- Challenges in the Diagnosis of Simple-Virilizing Congenital Adrenal Hyperplasia: A Case Report
- Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes
- Female Antiandrogens
- THE GENETICS OF CYP GENE VARIANTS IN ASSOCIATION WITH POLYCYSTIC OVARY SYNDROME: A NARRATIVE REVIEW